• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[肿瘤标志物在乳腺癌诊断和预后中的应用]

[Tumor markers in the diagnosis and prognosis of breast cancer].

作者信息

Seliuzhitskiĭ I V, Skvortsov S V, Lytsar B N, Khomenko L P

出版信息

Klin Med (Mosk). 1993;71(2):25-7.

PMID:8046917
Abstract

Serum levels of markers--mucinoid associated antigen (MAA), carcinoembryonal antigen (CEA) and carbohydrate antigen (CA-19-9) were measured in 78 breast cancer patients using enzyme immunoassay. It was found that MAA was most reliable of the above markers in staging breast cancer. A combined study of the latter is advisable in determination of breast cancer dissemination, in the control over the disease course and prognosis.

摘要

采用酶免疫分析法对78例乳腺癌患者的血清标志物——类黏蛋白相关抗原(MAA)、癌胚抗原(CEA)和糖类抗原(CA-19-9)水平进行了检测。结果发现,在乳腺癌分期中,MAA是上述标志物中最可靠的。在确定乳腺癌的播散情况、控制疾病进程及预后方面,建议对后者进行联合研究。

相似文献

1
[Tumor markers in the diagnosis and prognosis of breast cancer].[肿瘤标志物在乳腺癌诊断和预后中的应用]
Klin Med (Mosk). 1993;71(2):25-7.
2
[Carcinoembryonic antigen (CEA) and mucinous-like tumor associated antigen (MAC). Statistic correlation in advanced breast carcinoma].[癌胚抗原(CEA)与黏液样肿瘤相关抗原(MAC)。晚期乳腺癌中的统计学相关性]
Minerva Med. 1991 Dec;82(12):811-3.
3
Mammary serum antigen (MSA), Ca 549, CA 15-3 and CEA in breast cancer preoperative sensitivity and correlation to prognostic factors.乳腺癌术前乳腺血清抗原(MSA)、Ca 549、CA 15 - 3及癌胚抗原(CEA)的敏感性及其与预后因素的相关性
Anticancer Res. 1997 Jul-Aug;17(4B):2953-4.
4
A comparative study of four serological tumor markers for the detection of breast cancer.四种用于检测乳腺癌的血清学肿瘤标志物的比较研究。
Biomed Sci Instrum. 2003;39:408-14.
5
Serum CEA, CA 15-3, and MCA in breast cancer patients: a clinical evaluation.乳腺癌患者血清癌胚抗原、糖类抗原15-3和巨细胞动脉炎抗体的临床评估
Cancer Detect Prev. 1993;17(3):411-5.
6
[Comparison of the estrogen and progesterone receptor content of primary breast cancers without skeletal or visceral metastasis with tumor marker MCA, CEA and CA 15-3 serum concentration at the time of surgery].
Gynakol Rundsch. 1991;31 Suppl 2:397-8.
7
[Tumor markers in metastatic breast carcinoma: correlations with clinical response].
J Nucl Med Allied Sci. 1990 Oct-Dec;34(4 Suppl):127-30.
8
[Tumor markers MCA and CA-125 in the diagnosis and monitoring of breast cancer].
Vopr Onkol. 1992;38(4):433-9.
9
[Clinical usefulness of tumor markers in breast cancer].[肿瘤标志物在乳腺癌中的临床应用价值]
Rinsho Byori. 1993 Oct;41(10):1108-15.
10
[Is follow-up of breast cancer with CEA and CA 15-3 justified?].[癌胚抗原(CEA)和糖类抗原15-3(CA 15-3)用于乳腺癌随访是否合理?]
Helv Chir Acta. 1992 May;59(1):225-9.